WO1999047700A1 - Verfahren und vorrichtung zum nachweis einer nukleotidsequenz - Google Patents

Verfahren und vorrichtung zum nachweis einer nukleotidsequenz Download PDF

Info

Publication number
WO1999047700A1
WO1999047700A1 PCT/DE1999/000725 DE9900725W WO9947700A1 WO 1999047700 A1 WO1999047700 A1 WO 1999047700A1 DE 9900725 W DE9900725 W DE 9900725W WO 9947700 A1 WO9947700 A1 WO 9947700A1
Authority
WO
WIPO (PCT)
Prior art keywords
molecule
primer
microtiter plate
fluorophoric
bound
Prior art date
Application number
PCT/DE1999/000725
Other languages
German (de)
English (en)
French (fr)
Inventor
Wolf Bertling
Original Assignee
november Aktiengesellschaft Gesellschaft für Molekulare Medizin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by november Aktiengesellschaft Gesellschaft für Molekulare Medizin filed Critical november Aktiengesellschaft Gesellschaft für Molekulare Medizin
Priority to JP2000536883A priority Critical patent/JP2002506654A/ja
Priority to CA002323075A priority patent/CA2323075A1/en
Priority to EP99919084A priority patent/EP1064407A1/de
Publication of WO1999047700A1 publication Critical patent/WO1999047700A1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • C12Q1/6818Hybridisation assays characterised by the detection means involving interaction of two or more labels, e.g. resonant energy transfer

Definitions

  • the invention relates to a method according to the preamble of claim 1. It also relates to a microtiter plate and a kit for performing the method.
  • An amplification method is known from WO93 / 09250, in which a first primer is bound to a first phase.
  • a second primer is labeled with a fluorophore dye. If a nucleotide sequence to be detected is present, the labeled second primer accumulates on the solid phase. - In order to be able to recognize a sufficiently discriminating signal on the solid phase, it is necessary to carry out a washing step after the PCR. This step requires additional work. Contamination can also occur.
  • the object of the present invention is to eliminate the disadvantages of the prior art.
  • a simple and inexpensive method with improved sensitivity and less contamination probability is to be specified.
  • the concentration of the nucleotide sequence to be detected should be determinable as efficiently as possible.
  • At least one of the fluorophoric molecules is bound to the surface of a solid phase.
  • the method allows a qualitative and quantitative determination of the nucleotide sequence to be detected.
  • simple fluorescence measurement in particular online detection, is possible.
  • the process can be carried out simply and inexpensively because washing steps which increase the risk of contamination can be dispensed with.
  • a first primer is bound to the solid phase.
  • the first fluorophoric molecule may be bound to the solid phase via the first primer.
  • the first primer advantageously has a hairpin loop, and the first fluorophoric molecule is bound to one loop section and the second fluorophoric molecule opposite to the other loop section at a distance that enables the interaction.
  • the interaction is expediently eliminated by hybridization with a complementary strand complementary to the first primer or by a synthesis taking place on the first primer. The probability of contamination is further reduced by the aforementioned procedure.
  • the second fluorophoric molecule can also be bound to a second primer.
  • a second primer is in solution.
  • the first and second primers are advantageously hybridized in such a way that the interaction is generated.
  • the distance between the first and second fluorophoric molecules is preferably 2 to 12 nucleotides.
  • the solid phase can contain a, preferably electrically conductive, plastic, for example a polycarbonate, polycarbene, trimethylthiopene and / or triaminobenzene and / or carbon fibers. It has proven to be particularly advantageous that the solid phase is a microtiter plate.
  • the first molecule is an acceptor group and the second fluorophoric molecule is a donor group.
  • the acceptor group can be a 6-carboxy-tetramethyl-rhodamine and the donor group can be a 6-carboxy-fluorescein.
  • Other suitable donor / acceptor pairs are shown in the table below:
  • IAEDANS 5 - ((((2-fluorescein iodoacyl) amino) ethyl) amino) nap hathalene-isulonic acid)
  • first and second fluorophoric molecules can be interchanged.
  • the first or second fluorophoric molecule can be replaced by a quencher, preferably formed from 4- [4 '-dimethylaminophenylazo] benzene acid.
  • the fluorescence can be detected by means of a fluorometer connected to a data processing device, the concentration of the nucleotide sequence to be detected being determined from the change in the fluorescence intensity over time.
  • the second derivative of the fluorescence intensity over the number of amplification cycles carried out is preferably used as the reference point.
  • a microtiter plate with a top side having several trough-shaped depressions is provided for carrying out the method according to the invention, to which the first molecule is bound.
  • a first primer can be bound to the top side, the first molecule advantageously being bound to the surface via the first primer.
  • the first primer has a hairpin loop, and the first molecule is bound to a loop section and the second molecule opposite to a second loop section at a distance that enables the interaction.
  • a kit with a microtiter plate according to the invention and a primer provided with a second molecule is provided.
  • 7b the particle according to FIG. 7a in a fluorescence microscope image
  • 7c shows a particle bound to a second primer after a PCR without template DNA in a dark field image
  • a first primer P1 is bound to the top inside a cavity of a microtiter plate M made of polycarbonate or polypropylene.
  • the microtiter plate M can contain a controlled resistance heater. It can also be a resistance heating element itself.
  • a first fluorophore molecule F1 is bound to the first primer P1.
  • the nucleic acid sequence N to be detected contained in a target DNA and the further components necessary for carrying out a polymerase chain reaction (PCR) or ligase chain reaction (LCR) are pipetted into the cavities. These contain in particular a second primer P2 with a second fluorophore molecule F2 bound to it.
  • PCR polymerase chain reaction
  • LCR ligase chain reaction
  • the target DNA is denatured by increasing the temperature, i.e. separated into a strand S and a counter strand G.
  • the temperature is then reduced to 50 to 60 °.
  • the strand S binds to the first primer P1 with a complementary sequence section.
  • the counter strand G binds to the second primer P2 in the liquid.
  • the missing sequence section is then synthesized using a Taq DNA polymerase. Then the temperature is raised to 94 ° C., so that the synthesis strands containing the fluorophoric molecules F1, F2 as single strands, namely as synthesis strand SSI and as synthesis counter strand SGI, in the 8th
  • the second fluorophoric molecule F2 can also be incorporated into the synthesis strand SSI bound to nucleotides or a further nucleic acid sequence.
  • the temperature is reduced to 50 to 60 °.
  • the synthesis strand SSI and the synthesis counter strand SGI hybridize so that the first F1 and the second fluorophore molecule F2 are at a distance of 6 to 12 nucleotides.
  • Fig. 2 shows this schematically.
  • the first fluorophoric molecule F1 which is designed as a donor
  • the second fluorophoric molecule F2 which acts as an acceptor.
  • an increased fluorescence is observed on the second fluorophoric molecule F2.
  • the fluorescence is detected using a fluorometer. The detected values are forwarded to a data processing system.
  • the first primer P1 can also have a hairpin loop, the first fluorophore molecule F1 being bound to a first loop section and a quencher opposite to a loop section at a distance which enables the interaction.
  • the hairpin loop is closed, the interaction causes the fluorescence to be quenched.
  • the hairpin loop is opened by hybridization with a counter strand G complementary to the first primer P1 or by a synthesis taking place on the first primer P1.
  • the interaction between the fluorophore molecule and the quencher is broken. When the fluorophoric molecules are excited, fluorescence occurs.
  • the next PCR cycle is then initiated by increasing the temperature. This leads to a further increase in the Synthesis strand SSI and the synthesis counter strand SGI and consequently to an increase in the fluorescence intensity.
  • the change in the fluorescence intensity over the number of PCR or LCR cycles is a measure of the initial concentration of the target DNA: the more target DNA is contained in a sample, the faster the fluorescence intensity increases.
  • a microtiter plate M made of polycarbonate or polypropylene is used to carry out the aforementioned method.
  • the first primer P1 is bound to a polypropylene surface with its 5 'end via a linker, which preferably consists of 6 CH 2 groups.
  • the first primer P1 is bound to the polypropylene surface by the method of Weiler-J. and Hoheisel-JD. (Anal. Biochem., 1996; 243 (2): 218-27).
  • the first fluorophore molecule F1 is directly attached to the solid phase, i.e. the top of the microtiter plate M, bound.
  • the first primer P1 is bound to the solid phase in the vicinity of the first fluorophoric molecule F1.
  • After a hybridization of the synthesis strands SSI or the synthesis counterstrands SGI when there is an excitation, there is a radiation-free energy transition from the first fluorophoric molecule F1 (donor) to the second fluorophore molecule F2 (acceptor) and fluorescence there (FIG. 5).
  • FIG. 6 shows the fluorescence of PCR products of PCR with 3'-fluorophore-bearing primers.
  • the fluorescence of the PCR product is at an excitation wavelength of 496 im 10
  • the sample "PCR without template” is a PCR approach without HGH template DNA after 25 cycles.
  • the sample “PCR with template” is a PCR approach with HGH template DNA after 25 cycles.
  • the right column shows the PCR approach with template DNA, but without performing temperature cycles.
  • Example 1 Fluorescence energy transfer in PCR products from 3'-fluorophore-bearing primers
  • Two primers are synthesized which were labeled with fluorophoric groups in the region of the 3 'end.
  • a first primer with a length of 23 bases has the following sequence:
  • the thymidine at position 4 with respect to the 3 'end (printed in bold in the sequence) is labeled with 6-carboxyfluorescein (6-FAM).
  • 6-carboxyfluorescein (6-FAM).
  • the FAM group is linked via the amino group of the dT-C2-NH2 incorporated during the oligonucleotide synthesis.
  • the thymidine at position 3 with respect to the 3 'end (printed in bold in the sequence) is marked with carboxymethylrhodamine (TAMRA).
  • TAMRA carboxymethylrhodamine
  • the TAMRA group is linked via the a ino group of the dT-C2-NH2 incorporated during oligonucleotide synthesis.
  • the second primer is labeled with a biotin group at the 5 'end.
  • the synthesis scale is 0.2 ⁇ mol.
  • the primers are cleaned by HPLC.
  • the sequences of the primers are located immediately adjacent to a sequence section of the human growth hormone gene (HGH gene).
  • HGC 5'-ACCAGGAGTTTGTAAGCTCTTGG-GGAATGGGTGCGCATCAGG-3 '3' -TGGTCCTCAAACATTCGAGAACC-CCTTACCCACGCGTAGTCC-5 '
  • Second primer 3 * -CCTTACCCACGCGTAGTCC-Biotin-5 '
  • the first and second primers are reacted in a PCR using a template DNA covering the sequence portion of the HGH gene.
  • the PCR is carried out in a total volume of 50 ⁇ l, each with 0.5 ⁇ M primer, 2 units of Taq DNA polymerase and 1 ⁇ l HGH gene (10ng) in the corresponding PCR buffers (all solutions and enzymes from Boehringer, Mannheim). 25 cycles with an annealing temperature of 66 ° C (45 seconds), elongation temperature of 72 ° C (45 seconds) and a denaturation temperature of 94 ° C (30 seconds) are carried out. 12
  • the same PCR is carried out, leaving out the template DNA.
  • the PCR mixture is left at 4 ° C.
  • the PCR forms a PCR product in which the fluorophores of the first and second primers are arranged at a distance of a few bases on the strands of opposite polarity:
  • the fluorescence is determined in a fluorescence spectrometer with an excitation of 496nm (+/- 10nm) and an emission of 576n (+/- 10nm).
  • the fluorescence of the TAMRA group is increased by the PCR (FIG. 6). This increase in fluorescence indicates the formation of the expected PCR product. 13
  • Example 2 The same primers described in Example 1 are used for the PCR with 3 '-labelled and immobilized primers.
  • the 5 '-biotinylated second primer according to Example 1 is bound by the PCR to streptavidin-coated, super-paramagnetic particles with a size of approximately 2.8 ⁇ m in diameter (M-280 Dynabeads, Dynal, Hamburg).
  • the particles (10 ⁇ g / ⁇ l; 6.7 x 10 8 particles / ml suspended in phosphate buffered saline (PBS) pH 7.4 with B / W buffer (10 mm Tris-Cl, ImM EDTA, 2M NaCl) pH 7 , 5 and brought to a concentration of 5 ⁇ g / ⁇ l in B / W buffer
  • B / W buffer 10 mm Tris-Cl, ImM EDTA, 2M NaCl
  • TE lOmM TrisCl, 0.2mM EDTA pH8
  • the PCR according to Example 1 is carried out with the second primer bound to the supermagnetic particle.
  • 1 ⁇ l of the suspension of particle-bound primer-2 is used instead of the free second primer.
  • the particles are washed several times in TE and analyzed in a fluorescence microscope. The attachment of the 6-FAM-labeled first primer to the particles is examined. 7A shows the fluorescence of the particles after completion. A fluorescence of the particles can be observed in the PCR approach shown in FIG. 7B. 14

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
PCT/DE1999/000725 1998-03-18 1999-03-16 Verfahren und vorrichtung zum nachweis einer nukleotidsequenz WO1999047700A1 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2000536883A JP2002506654A (ja) 1998-03-18 1999-03-16 ヌクレオチド配列を検出するための方法と装置
CA002323075A CA2323075A1 (en) 1998-03-18 1999-03-16 Method and device for detecting a nucleotide sequence
EP99919084A EP1064407A1 (de) 1998-03-18 1999-03-16 Verfahren und vorrichtung zum nachweis einer nukleotidsequenz

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19811729.9 1998-03-18
DE19811729A DE19811729C2 (de) 1998-03-18 1998-03-18 Verfahren und Vorrichtung zum Nachweis einer Nukleotidsequenz

Publications (1)

Publication Number Publication Date
WO1999047700A1 true WO1999047700A1 (de) 1999-09-23

Family

ID=7861305

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1999/000725 WO1999047700A1 (de) 1998-03-18 1999-03-16 Verfahren und vorrichtung zum nachweis einer nukleotidsequenz

Country Status (5)

Country Link
EP (1) EP1064407A1 (ja)
JP (1) JP2002506654A (ja)
CA (1) CA2323075A1 (ja)
DE (1) DE19811729C2 (ja)
WO (1) WO1999047700A1 (ja)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19960076C2 (de) * 1999-12-13 2002-12-05 November Ag Molekulare Medizin Verfahren und Vorrichtung zum Nachweis und zur Quantifizierung von Biomolekülen
WO2013055647A1 (en) 2011-10-11 2013-04-18 Enzo Life Sciences, Inc. Fluorescent dyes
US9068948B2 (en) 2002-03-12 2015-06-30 Enzo Life Sciences, Inc. Processes for detection of nucleic acids
US9353405B2 (en) 2002-03-12 2016-05-31 Enzo Life Sciences, Inc. Optimized real time nucleic acid detection processes
CN112996899A (zh) * 2018-11-09 2021-06-18 横河电机株式会社 核酸序列检测用装置

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10111420A1 (de) * 2001-03-09 2002-09-12 Gnothis Holding Sa Ecublens Bestimmung von Analyten durch Fluoreszenz-Korrelationsspektroskopie
JP4710283B2 (ja) * 2004-09-08 2011-06-29 富士レビオ株式会社 核酸配列の増幅法および検出法
US7955802B2 (en) 2006-12-13 2011-06-07 Luminex Corporation Systems and methods for multiplex analysis of PCR in real time

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996143A (en) * 1985-12-23 1991-02-26 Syngene, Inc. Fluorescent stokes shift probes for polynucleotide hybridization
WO1993009250A1 (en) * 1991-11-01 1993-05-13 Adelaide Children's Hospital Solid phase amplification process
EP0745690A2 (en) * 1995-05-12 1996-12-04 The Public Health Research Institute Of The City Of New York, Inc. Detectably labeled dual conformation oligonucleotide Probes, Assays and Kits
US5607834A (en) * 1992-12-10 1997-03-04 Maine Medical Center Research Institute Fluorescent imperfect hairpin nucleic acid probes
WO1997022719A1 (en) * 1995-12-18 1997-06-26 Washington University Method for nucleic acid analysis using fluorescence resonance energy transfer
WO1997031256A2 (en) * 1996-02-09 1997-08-28 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
DE29521620U1 (de) * 1994-02-01 1997-11-13 The Regents Of The University Of California, Berkeley, Calif. Fluoreszierende Marker und diese enthaltender Reagenzsatz
WO1997046714A1 (en) * 1996-06-04 1997-12-11 University Of Utah Research Foundation Monitoring hybridization during pcr
US5723591A (en) * 1994-11-16 1998-03-03 Perkin-Elmer Corporation Self-quenching fluorescence probe

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996143A (en) * 1985-12-23 1991-02-26 Syngene, Inc. Fluorescent stokes shift probes for polynucleotide hybridization
WO1993009250A1 (en) * 1991-11-01 1993-05-13 Adelaide Children's Hospital Solid phase amplification process
US5607834A (en) * 1992-12-10 1997-03-04 Maine Medical Center Research Institute Fluorescent imperfect hairpin nucleic acid probes
DE29521620U1 (de) * 1994-02-01 1997-11-13 The Regents Of The University Of California, Berkeley, Calif. Fluoreszierende Marker und diese enthaltender Reagenzsatz
US5723591A (en) * 1994-11-16 1998-03-03 Perkin-Elmer Corporation Self-quenching fluorescence probe
EP0745690A2 (en) * 1995-05-12 1996-12-04 The Public Health Research Institute Of The City Of New York, Inc. Detectably labeled dual conformation oligonucleotide Probes, Assays and Kits
WO1997022719A1 (en) * 1995-12-18 1997-06-26 Washington University Method for nucleic acid analysis using fluorescence resonance energy transfer
WO1997031256A2 (en) * 1996-02-09 1997-08-28 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
WO1997046714A1 (en) * 1996-06-04 1997-12-11 University Of Utah Research Foundation Monitoring hybridization during pcr

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JU J ET AL: "DESIGN AND SYNTHESIS OF FLUORESCENCE ENERGY TRANSFER DYE-LABELED PRIMERS AND THEIR APPLICATION FOR DNA SEQUENCING AND ANALYSIS", ANALYTICAL BIOCHEMISTRY, vol. 231, no. 1, 10 October 1995 (1995-10-10), pages 131 - 140, XP000536518, ISSN: 0003-2697 *
NAZARENKO ET AL: "A CLOSED TUBE FORMAT FOR AMPLIFICATION AND DETECTION OF DNA BASED ENERGY TRANSFER", NUCLEIC ACIDS RESEARCH, vol. 25, no. 12, 1 January 1997 (1997-01-01), pages 2516 - 2521, XP002094959, ISSN: 0305-1048 *
TYAGI S ET AL: "MOLECULAR BEACONS: PROBES THAT FLUORESCE UPON HYBRIDIZATION", BIO/TECHNOLOGY, vol. 14, 1 March 1996 (1996-03-01), pages 303 - 308, XP000196024, ISSN: 0733-222X *

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19960076C2 (de) * 1999-12-13 2002-12-05 November Ag Molekulare Medizin Verfahren und Vorrichtung zum Nachweis und zur Quantifizierung von Biomolekülen
US10144957B2 (en) 2002-03-12 2018-12-04 Enzo Life Sciences, Inc. Optimized real time nucleic acid detection processes
US9068948B2 (en) 2002-03-12 2015-06-30 Enzo Life Sciences, Inc. Processes for detection of nucleic acids
US9261460B2 (en) * 2002-03-12 2016-02-16 Enzo Life Sciences, Inc. Real-time nucleic acid detection processes and compositions
US9316587B2 (en) 2002-03-12 2016-04-19 Enzo Life Sciences, Inc. Processes for quantitative or qualitative detection of single-stranded or double-stranded nucleic acids
US9353405B2 (en) 2002-03-12 2016-05-31 Enzo Life Sciences, Inc. Optimized real time nucleic acid detection processes
US9416153B2 (en) 2011-10-11 2016-08-16 Enzo Life Sciences, Inc. Fluorescent dyes
US10106573B2 (en) 2011-10-11 2018-10-23 Enzo Life Sciences, Inc. Fluorescent dyes and methods of use thereof
WO2013055647A1 (en) 2011-10-11 2013-04-18 Enzo Life Sciences, Inc. Fluorescent dyes
EP3747877A1 (en) 2011-10-11 2020-12-09 Enzo Life Sciences, Inc., c/o Enzo Biochem, Inc. Fluorescent dyes
US10875886B2 (en) 2011-10-11 2020-12-29 Enzo Life Sciences, Inc. Fluorescent dyes and methods of use thereof
US11939350B2 (en) 2011-10-11 2024-03-26 Enzo Life Sciences, Inc. Fluorescent dyes and methods of use thereof
CN112996899A (zh) * 2018-11-09 2021-06-18 横河电机株式会社 核酸序列检测用装置
CN112996899B (zh) * 2018-11-09 2024-07-05 横河电机株式会社 核酸序列检测用装置

Also Published As

Publication number Publication date
JP2002506654A (ja) 2002-03-05
DE19811729A1 (de) 1999-09-23
DE19811729C2 (de) 2000-05-18
CA2323075A1 (en) 1999-09-23
EP1064407A1 (de) 2001-01-03

Similar Documents

Publication Publication Date Title
DE69531133T2 (de) Verfahren zur Dämpfung der Fluoreszene in Lösung von Fluoreszenzmarkierten Oligonucleotidsonden
DE60125243T2 (de) Polynukleotid-sequenzassay
DE69816488T2 (de) Pcr-primerkonstruktionen für ein integriertes signalsystem
DE60310532T2 (de) Bestimmung von nukleinsäuren
DE602005000485T2 (de) Nukleinsäurenachweisverfahren mittels mehreren Paaren von Donorflurophoren und Quenchemolekülen in derselben Sonde
DE69814848T2 (de) Untersuchung von nukleotiden in loesung mit hilfe von pna-sonden
WO2002038806A2 (de) Nachweis von nukleinsäure-polymorphismen
EP2167685B1 (de) Verfahren und sonden/primersystem zum "real time" nachweis eines nukleinsäuretargets
DE602004012273T2 (de) Bestimmung der sequenz eines polynukleotids
DE60204874T2 (de) Verfahren zur nachweis von nukleinsäuren
WO2018114674A1 (de) Zweiteilige mediatorsonde
WO2001036668A1 (de) Farbstoffmarkiertes oligonukleotid zum markieren eines nukleinsäuremoleküls
WO1999047701A1 (de) Verfahren zum nachweis einer nukleotidsequenz
DE19811729C2 (de) Verfahren und Vorrichtung zum Nachweis einer Nukleotidsequenz
DE60313828T2 (de) Verfahren zum Nachweis von Nukleinsäuren mit Fluoreszenzfarbstoff-markierten Sonden welches auf der Analyse von Schmelzkurven basiert
DE69630517T2 (de) Sonde zur Verwendung in der Nukleinsäurenanalyse und Detektionsverfahren auf der Basis von Excimer-Fluoreszenz
DE102007013099A1 (de) Verfahren und Testkit zum schnellen Nachweis spezifischer Nukleinsäuresequenzen, insbesondere zum Nachweis von Mutationen oder SNP's
WO1999047702A2 (de) Verfahren und vorrichtung zum identifizieren einer markierung
DE602006000713T2 (de) Verfahren zur Verbesserung der Unterscheidung von einer einzelnen Basenfehlanpaarung durch die Verwendung von "hurdle" DNAs und Sonden mit artifiziellen Fehlpaarungen
WO2007110126A1 (de) Verfahren zur mikroskopischen ortsbestimmung eines ausgewählten, intrazellulären dna-abschnitts bekannter nukleotidsequenz
DE60017750T2 (de) Amplifizierungsverfahren zum Nachweis von zu bestimmenden Nucleinsäuren und Anwendung von Flourszenzenergieübertragung
DE19806962B4 (de) Markierung von Nukleinsäuren mit speziellen Probengemischen
DE112016007245T5 (de) Verfahren zum Nachweisen von Ziel-Nukleinsäuremolekülen
DE19858588B4 (de) Farbstoffmarkiertes Oligonukleotid zum Markieren eines Nukleinsäuremoleküls
WO2012069484A2 (de) Verfahren zum qualitativen und quantitativen nachweis von spezifischen nukleinsäuresequenzen in echtzeit

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1999919084

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2323075

Country of ref document: CA

Ref country code: CA

Ref document number: 2323075

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 09646303

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1999919084

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1999919084

Country of ref document: EP